Valuation: Shivalik Rasayan Limited

Market Cap 3.49B 36.42M 32.02M 29.8M 27.37M 51.4M 52.07M 354M 138M 1.72B 137M 134M 5.96B P/E 2024
69.1x
P/E 2025 59.1x
Enterprise Value 4.26B 44.42M 39.05M 36.35M 33.39M 62.69M 63.52M 432M 169M 2.1B 167M 163M 7.27B EV / Sales 2024
3.49x
EV / Sales 2025 3.4x
Free-Float
41.05%
Yield 2024
0.09%
Yield 2025 0.08%
07-23 Shivalik Rasayan Limited announced that it expects to receive INR 152.25 million in funding from Bishnoi Exports Private Limited, Growel Remedies Limited, Kim Ginnerup ApS and other investors CI
05-27 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
05-27 Shivalik Rasayan Limited Announces Resignation of Sanjay Bansal as Non-Executive Director, Effective May 27, 2026 CI
05-27 Shivalik Rasayan Limited Recommends Final Dividend for the Financial Year 2025-26 CI
05-27 Shivalik Rasayan Ltd March-quarter consol net profit 45.3 million rupees RE
02-13 Shivalik Rasayan Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
11-14 Shivalik Rasayan Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25-09-29 Shivalik Rasayan Limited Approves the Re-Designation of Mr. Ashwani Kumar Sharma as a Non-Executive, Non-Independent Director CI
25-08-12 Shivalik Rasayan Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
25-05-30 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
25-05-29 Shivalik Rasayan Limited announces Annual dividend, payable on October 27, 2025 CI
25-04-23 Medicamen Biotech Limited announced that it has received INR 535.6816 million in funding from Kim Ginnerup ApS, Shivalik Rasayan Limited, VERALOGIX HOLDINGS LTD and other investors CI
25-02-25 Medicamen Biotech Limited announced that it expects to receive INR 775.7875 million in funding from Kim Ginnerup ApS, Shivalik Rasayan Limited, VERALOGIX HOLDINGS LTD CI
1 day+0.44%
1 week+10.13%
Current month+11.06%
1 month+16.60%
3 months-4.67%
6 months-16.36%
Current year-26.08%
1 week 233.85
Extreme 233.85
271.4
1 month 211.45
Extreme 211.45
271.4
Current year 206
Extreme 206
371.3
1 year 206
Extreme 206
652.75
3 years 206
Extreme 206
890.05
5 years 206
Extreme 206
1,196.8
10 years 53.1
Extreme 53.1
1,196.8
Manager TitleAgeSince
Chief Executive Officer 64 2018-11-16
Director of Finance/CFO - 2001-10-31
Chief Tech/Sci/R&D Officer - 2024-01-10
Director TitleAgeSince
Chairman 61 2002-02-22
Director/Board Member 67 2003-07-17
Director/Board Member - 2018-11-12
Date Insider Type Main position Quantity % Market Cap.
7/1/24 Don 21,500 0.1382%
6/26/24 Sell 108,500 0.6973%
Change 5-day change 1-year change 3-year change Capi.($)
+0.44%+10.13%-50.98%-66.63% 43.01M
-1.87%+0.92%+19.27%+57.55% 58.58B
+0.11%-.--%-.--%-.--% 12.96B
-1.50%+3.99%+24.84%+166.83% 10.67B
+1.39%+3.84%+17.98%+59.39% 7.86B
-2.46%+3.00%-24.26%-22.09% 6.65B
+1.00%-0.68%-11.16%+73.55% 5.53B
-1.83%-3.43%-18.17%-4.49% 5.35B
+0.82%+1.84%+22.67%+32.55% 4.76B
-1.15%+1.23%-33.99%-24.26% 4.34B
Average -0.50%+2.92%-5.38%+27.24% 11.67B
Weighted average by Cap. -1.15%+1.41%+10.05%+50.54%

Financials

2024 2025
Net sales 2.72B 28.32M 24.89M 23.17M 21.28M 39.96M 40.49M 275M 108M 1.34B 106M 104M 4.63B 3.1B 32.28M 28.38M 26.41M 24.26M 45.55M 46.15M 314M 123M 1.53B 121M 119M 5.28B
Net income 127M 1.33M 1.17M 1.09M 997K 1.87M 1.9M 12.9M 5.04M 62.8M 4.98M 4.87M 217M 167M 1.74M 1.53M 1.42M 1.31M 2.46M 2.49M 16.93M 6.61M 82.44M 6.54M 6.39M 285M
Net Debt 482M 5.03M 4.42M 4.12M 3.78M 7.1M 7.19M 48.92M 19.11M 238M 18.88M 18.47M 823M 768M 8M 7.04M 6.55M 6.02M 11.3M 11.44M 77.85M 30.41M 379M 30.05M 29.4M 1.31B
Logo Shivalik Rasayan Limited
Shivalik Rasayan Limited is an India-based company. The Company’s segments are engaged in agrochemicals, active pharma ingredients (API), and pharma formulation. It is the producer of Malathion Technical and Dimethoate Technical. Malathion Technical is a non-systemic, wide spectrum organophosphorus (OP) based contact insecticide. Dimethoate Technical is used in preparation of formulations used in the control of a range of insects and mites. It also manufactures organophosphorus-based insecticides and chemicals. It has a diverse product range and product mix in order to serve consumer requirements. The APIs are being developed and manufactured in the niche area of oncology, ARVs, cardiovascular, metabolic disorders and immunology. It offers solutions from product selection to development to commercialization for a range of oncology and non-oncology products. The Company’s oncology products include Azacitidine, Busulfan, Bortezomib, and various others.
Employees
275
Date Price Change Volume
26-07-28 263.05 +0.44% 1,884
26-07-27 ₹261.90 +2.73% 3,091
26-07-24 ₹254.95 +4.98% 20,304
26-07-23 ₹242.85 -0.98% 6,447
26-07-22 ₹245.25 +2.68% 16,682
  1. Stock Market
  2. Stocks
  3. SHIVALIK Stock